Annals of vascular surgery · 2025
Penetrating Aortic Ulcers and Pseudoaneurysms Managed with Endovascular Aortic Arch Repair.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nana Petroula, Apostolidis George, Torrealba Jose I, Panuccio Giuseppe, Spanos Konstantinos, Kölbel Tilo
Аннотация
BACKGROUND: This study investigated the outcomes of fenestrated/branched aortic arch repair (f/bTEVAR) in patients with chronic penetrating aortic ulcers (PAU) or pseudoaneurysms.
METHODS: A single-center retrospective analysis of patients managed with f/bTEVAR for PAU or pseudoaneurysms involving the aortic arch between September 1st, 2011, and December 31st, 2023, was conducted. Any outpouching-like lesion leading to an aortic diameter ≥50% of the normal one was considered pseudoaneurysm, while similar lesions leading to a diameter increase <50% were considered PAUs. Primary outcomes were technical success, mortality and stroke at 30 days.
RESULTS: Twenty-three patients had PAU and 28 pseudoaneurysm [age: 72 (Q1:67, Q3:76) years, 78.4% males]. Peripheral arterial disease was more common among PAU patients (PAU: 43.5% vs. pseudoaneurysm: 10.7%, P = 0.007). Only patients with pseudoaneurysm underwent urgent repair (PAU: 0% vs. pseudoaneurysms: 25%, P = 0.03). No differences in device configuration were detected. Technical success was 100% in PAUs and 92.8% in pseudoaneurysms (P = 0.67). Thirty-day mortality was 4.3% in PAUs versus 10.7% in pseudoaneurysms (P = 0.40). Four (7.8%) major strokes were recorded; 4.3% in PAUs versus 10.7% in pseudoaneurysms (P = 0.40). The median follow-up was 12 months (Q1: 1, Q3: 24). The survival was 80.6% (SE 8.8%) in PAUs versus 79.6% (SE 8.2%) in pseudoaneurysms (log-rank, P = 0.45).
CONCLUSIONS: In this small cohort of f/bTEVAR for PAUs versus pseudoaneurysms, technical success and mortality were similar. The major stroke rate exceeded 10.0% in pseudoaneurysm patients, alarming on the safety of the procedure in this subgroup. Larger studies are needed to verify the need for differentiation of these pathologies.
METHODS: A single-center retrospective analysis of patients managed with f/bTEVAR for PAU or pseudoaneurysms involving the aortic arch between September 1st, 2011, and December 31st, 2023, was conducted. Any outpouching-like lesion leading to an aortic diameter ≥50% of the normal one was considered pseudoaneurysm, while similar lesions leading to a diameter increase <50% were considered PAUs. Primary outcomes were technical success, mortality and stroke at 30 days.
RESULTS: Twenty-three patients had PAU and 28 pseudoaneurysm [age: 72 (Q1:67, Q3:76) years, 78.4% males]. Peripheral arterial disease was more common among PAU patients (PAU: 43.5% vs. pseudoaneurysm: 10.7%, P = 0.007). Only patients with pseudoaneurysm underwent urgent repair (PAU: 0% vs. pseudoaneurysms: 25%, P = 0.03). No differences in device configuration were detected. Technical success was 100% in PAUs and 92.8% in pseudoaneurysms (P = 0.67). Thirty-day mortality was 4.3% in PAUs versus 10.7% in pseudoaneurysms (P = 0.40). Four (7.8%) major strokes were recorded; 4.3% in PAUs versus 10.7% in pseudoaneurysms (P = 0.40). The median follow-up was 12 months (Q1: 1, Q3: 24). The survival was 80.6% (SE 8.8%) in PAUs versus 79.6% (SE 8.2%) in pseudoaneurysms (log-rank, P = 0.45).
CONCLUSIONS: In this small cohort of f/bTEVAR for PAUs versus pseudoaneurysms, technical success and mortality were similar. The major stroke rate exceeded 10.0% in pseudoaneurysm patients, alarming on the safety of the procedure in this subgroup. Larger studies are needed to verify the need for differentiation of these pathologies.
Предметные рубрики MeSH
HumansMaleRetrospective StudiesAneurysm, FalseEndovascular ProceduresAgedUlcerFemaleTreatment OutcomeBlood Vessel Prosthesis ImplantationTime FactorsRisk FactorsAorta, ThoracicAortic DiseasesBlood Vessel ProsthesisChronic DiseaseMiddle AgedStrokeAortic Aneurysm, ThoracicPenetrating Atherosclerotic Ulcer